Familial Breast Cancer
101 – 110 of 147
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
- Contribution to journal › Article
-
Mark
Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification
- Contribution to journal › Article
-
Mark
High-definition spatial transcriptomics for in situ tissue profiling
- Contribution to journal › Article
- 2018
-
Mark
BRCAsearch : written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
- Contribution to journal › Article
-
Mark
Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer
- Contribution to journal › Article
-
Mark
Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study : experiences from re-contacting mutation carriers and relatives
- Contribution to journal › Article
-
Mark
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
- Contribution to journal › Article
-
Mark
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
- Contribution to journal › Article
-
Mark
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility
- Contribution to journal › Article
-
Mark
Intact glucose uptake despite deteriorating signaling in adipocytes with high-fat feeding
- Contribution to journal › Article
